Clinical trial
Neoadjuvant Endocrinotherapy of Mamma Carcinoma With Exemestane
NCT00291798 is registered in ClinicalTrials.gov with Austrian Breast & Colorectal Cancer Study Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant Endocrinotherapy of Mamma Carcinoma With Exemestane
- Lead sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2000
- Completion date
- March 31, 2009
- Enrollment
- 98
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer